Samsung Biologics Statistics

Total Valuation

KRX:207940 has a market cap or net worth of KRW 69.62 trillion. The enterprise value is 68.92 trillion.

Market Cap	69.62T
Enterprise Value	68.92T

Important Dates

The last earnings date was Wednesday, April 22, 2026.

Earnings Date	Apr 22, 2026
Ex-Dividend Date	n/a

Share Statistics

KRX:207940 has 46.29 million shares outstanding.

Current Share Class	46.29M
Shares Outstanding	46.29M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	13.44%
Float	11.83M

Valuation Ratios

The trailing PE ratio is 36.22 and the forward PE ratio is 36.15. KRX:207940's PEG ratio is 0.66.

PE Ratio	36.22
Forward PE	36.15
PS Ratio	14.46
PB Ratio	8.79
P/TBV Ratio	8.79
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	0.66

Financial Ratio History

Enterprise Valuation

EV / Earnings	35.86
EV / Sales	14.32
EV / EBITDA	n/a
EV / EBIT	31.03
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.70, with a Debt / Equity ratio of 0.12.

Current Ratio	1.70
Quick Ratio	0.59
Debt / Equity	0.12
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	23.76%
Return on Capital Employed (ROCE)	24.00%
Weighted Average Cost of Capital (WACC)	6.01%
Revenue Per Employee	926.66M
Profits Per Employee	369.97M
Employee Count	4,770
Asset Turnover	0.33
Inventory Turnover	n/a

Taxes

In the past 12 months, KRX:207940 has paid 569.00 billion in taxes.

Income Tax	569.00B
Effective Tax Rate	24.52%

Stock Price Statistics

The stock price has decreased by -5.43% in the last 52 weeks. The beta is 0.33, so KRX:207940's price volatility has been lower than the market average.

Beta (5Y)	0.33
52-Week Price Change	-5.43%
50-Day Moving Average	1,605.00
200-Day Moving Average	1,644.00
Relative Strength Index (RSI)	39.60
Average Volume (20 Days)	49,365

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:207940 had revenue of KRW 4.81 trillion and earned 1.92 trillion in profits.

Revenue	4.81T
Gross Profit	2.66T
Operating Income	2.22T
Pretax Income	2.32T
Net Income	1.92T
EBITDA	n/a
EBIT	2.22T
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 1.62 trillion in cash and 919.00 billion in debt, giving a net cash position of 701.00 billion or 15,143.35 per share.

Cash & Cash Equivalents	1.62T
Total Debt	919.00B
Net Cash	701.00B
Net Cash Per Share	15,143.35
Equity (Book Value)	7.92T
Book Value Per Share	n/a
Working Capital	1.92T

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	628.65B
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 55.15%, with operating and profit margins of 46.14% and 39.93%.

Gross Margin	55.15%
Operating Margin	46.14%
Pretax Margin	48.21%
Profit Margin	39.93%
EBITDA Margin	n/a
EBIT Margin	46.14%
FCF Margin	n/a

Dividends & Yields

KRX:207940 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	2.76%
FCF Yield	n/a

Stock Splits

The last stock split was on October 30, 2025. It was a reverse split with a ratio of 0.6503913.

Last Split Date	Oct 30, 2025
Split Type	Reverse
Split Ratio	0.6503913

Scores

KRX:207940 has an Altman Z-Score of 13.26 and a Piotroski F-Score of 5.

Altman Z-Score	13.26
Piotroski F-Score	5